Bariatric Surgery Cuts Cancer Risk Across Ages and Sexes

Bariatric surgery lowers the risk of cancers linked to obesity by roughly a fifth, and the protection looks the same for men and women and for younger and older patients, according to a large Nordic registry study published in JAMA Surgery. Drawing on health records from more than 780,000 people with obesity in Sweden, Denmark and Finland, the researchers found that nearly 100,000 people who had obesity surgery developed obesity-related cancers at a notably lower rate than people with obesity who did not have surgery.

The result matters because earlier research had suggested the cancer-preventing effect of surgery was stronger in women, and it was unclear whether the benefit held for younger patients. This analysis, reported by Medical Xpress, says the protective pattern holds across the board, which the authors say supports equitable access to the procedure for patients with obesity of all ages and both sexes.

The strongest drops were in liver and reproductive cancers

across the full cohort, surgery was associated with an adjusted incidence rate ratio of 0.81, which translates to about 19 percent fewer of these cancers than expected without the operation. When the team broke the results down by cancer type, the biggest reductions appeared in liver cancer, with an incidence rate ratio of 0.49, and endometrial cancer at 0.51, each roughly half the rate seen without surgery. Ovarian cancer risk was lower too, at 0.73.

The age split tells the same story at both ends. Patients who had surgery between ages 18 and 39 landed at a ratio of 0.80, while those operated on between 40 and 59 showed essentially the identical result, with the statistical test for a difference between the groups showing nothing meaningful. For cancers that occur in both sexes, the association was similar in men and women.

"We found that the reduction in cancer risk after obesity surgery was similar across age groups and between women and men, suggesting that the long-term health benefits of surgery extend to a broad range of patients," said Cecilia Radkiewicz, a researcher at the Department of Molecular Medicine and Surgery at Karolinska Institutet and the study's first author. The work was carried out with collaborating institutions across the three countries.

How this compares with earlier evidence

The headline result of the new analysis is straightforward: Bariatric Surgery Cuts Cancer Risk Across Ages and Sexes. The new results line up with earlier long-running research that linked bariatric surgery to lower cancer incidence and mortality, including the landmark Swedish Obese Subjects study and more recent registry analyses. What sets this work apart is its scale and its explicit test of whether age at surgery or sex changes the effect, questions that previous studies had left largely unexplored, especially for individual gastrointestinal cancer types where findings had been inconsistent.

Why the findings land differently for younger patients

Gastrointestinal cancers linked to obesity are increasing in Western populations, a trend that has put younger adults in the spotlight. Knowing that surgery's protective association applies to patients as young as 18 gives clinicians one more long-term factor to weigh when people with severe obesity are considering treatment options. The authors of the new study drew on registry data that tracked diagnoses, operations and cancers over many years, and they adjusted their comparisons for age, sex, calendar year, country and obesity-related health conditions.

For readers, the takeaway is less about surgery as a magic shield and more about treating obesity itself as a modifiable cancer risk. The researchers argue that effective obesity treatment carries a cancer-prevention dividend on top of its better-known metabolic benefits, and that health systems should not gatekeep the operation by age or sex.

One warning sign stands out in the data

The picture is not uniformly positive. The team reported that pancreatic cancer risk was higher after surgery, particularly among younger adults, where the incidence rate ratio reached 2.21. That finding was statistically significant, and it contrasts with the protective pattern seen for the other cancer types in the study.

The researchers caution that registry studies observe patterns rather than proving cause and effect, and the pancreatic finding needs more investigation before anyone can say why it appears. It is a reminder that bariatric surgery is a serious medical intervention with trade-offs, and anyone considering it should work through the risks and benefits with their own clinical team rather than reading one study as a prescription.

Related coverage: Prostate Cancer in Younger Adults Is Rising Fast.